Investigating the effectiveness of virtual reality based relaxation in reducing the stress

Investigating the effectiveness of immersive virtual reality based relaxation in reducing the stress of substance abuse patients undergoing detoxification

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220316054306N2

Enrollment

Registered

2023-09-16

Start date

2023-08-27

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid abuse. Opioid abuse, uncomplicated

Interventions

Intervention 1: Intervention group: Relaxation-based virtual reality. The patients have been using a virtual reality device to view nature scenes for 12 minutes. Intervention 2: Control group: Interve

Eligibility

Sex/Gender

Male

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Age between 18-50 years Do not have any neurological disorders Do not have any psychotic disorders Being under detoxification

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Negetive and positive affects based on scores on positive and negative affect schedule. Timepoint: Before and after intervention. Method of measurement: Positive and Negative Affect Schedule.;Perceived stress score. Timepoint: Before and after intervention. Method of measurement: Cohen's perceived stress scale.;Heart rate. Timepoint: During 12 minutes of intervention. Method of measurement: Procomp-5 with ECG/EKG sensor.;Abdominal breath rate. Timepoint: During 12 minutes of intervention. Method of measurement: Procomp-5 with respiration sensor.;Skin conductance. Timepoint: During 12 minutes of intervention. Method of measurement: Procomp-5 with Skin Conductance sensor.	—

Measure

Time frame

Negetive and positive affects based on scores on positive and negative affect schedule. Timepoint: Before and after intervention. Method of measurement: Positive and Negative Affect Schedule.;Perceived stress score. Timepoint: Before and after intervention. Method of measurement: Cohen's perceived stress scale.;Heart rate. Timepoint: During 12 minutes of intervention. Method of measurement: Procomp-5 with ECG/EKG sensor.;Abdominal breath rate. Timepoint: During 12 minutes of intervention. Method of measurement: Procomp-5 with respiration sensor.;Skin conductance. Timepoint: During 12 minutes of intervention. Method of measurement: Procomp-5 with Skin Conductance sensor.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShahab

Shahid Beheshti University of Medical Sciences

lotfiniashahab@sbmu.ac.ir+98 21 2243 9770

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026